1.

A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.

Chrysostomou AC, Vrancken B, Koumbaris G, Themistokleous G, Aristokleous A, Masia C, Eleftheriou C, Iοannou C, Stylianou DC, Ioannides M, Petrou P, Georgiou V, Hatziyianni A, Lemey P, Vandamme AM, Patsalis PP, Kostrikis LG.

Viruses. 2021 Jun 9;13(6):1098.

PMID: 34207490 

2.

Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern.

Chrysostomou AC, Vrancken B, Haralambous C, Alexandrou M, Aristokleous A, Christodoulou C, Gregoriou I, Ioannides M, Kalakouta O, Karagiannis C, Koumbaris G, Loizides C, Mendris M, Papastergiou P, Patsalis PC, Pieridou D, Richter J, Schmitt M, Shammas C, Stylianou DC, Themistokleous G, The Comessar Network, Lemey P, Kostrikis LG.

Viruses. 2022 Dec 30;15(1):108.

PMID: 36680148 

3.

A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2.

Chrysostomou AC, Hezka Rodosthenous J, Topcu C, Papa C, Aristokleous A, Stathi G, Christodoulou C, Eleftheriou C, Stylianou DC, Kostrikis

Life (Basel). 2021 Oct 27;11(11):1146.

PMID: 34833022 

4.

Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains.

Chrysostomou AC, Topcu C, Stylianou DC, Hezka J, Kostrikis LG.

Infect Genet Evol. 2020 Jul;81:104243.

PMID: 32061896

5.

The development of inovirus-associated vector vaccines using phage-display technologies.

Stern Z, Stylianou DC, Kostrikis LG.

Expert Rev Vaccines. 2019 Sep;18(9):913-920.

PMID: 31373843

6.

HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection.

Paraskevis D, Stylianou DC, Hezka J, Stern Z, Oikonomopoulou M, Mamais I; Cyprus PWID Network, Kostrikis LG.

Sci Rep. 2019 Jul 11;9(1):10077.

PMID: 31296903

7.

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.

Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG.

Viruses. 2018 Dec 19;10(12):729.

PMID: 30572620

8.

HIV-1 transmission networks across Cyprus (2010-2012).

Kostrikis LG, Hezka J, Stylianou DC, Kostaki E, Andreou M, Kousiappa I, Paraskevis D, Demetriades I.

PLoS One. 2018 Apr 23;13(4):e0195660.

PMID: 29684083

9.

HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012.

Pineda-Peña AC, Theys K, Stylianou DC, Demetriades I; SPREAD/ESAR Program, Abecasis AB, Kostrikis LG.

Sci Rep. 2018 Jan 26;8(1):1702.

PMID: 29374182

10.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

PMID: 27262355

11.

Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.

Hassapis KA, Stylianou DC, Kostrikis LG.

Viruses. 2014 Dec 17;6(12):5047-76.

PMID: 25525909

12.

Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Stylianou DC, Auf der Maur A, Kodack DP, Henke RT, Hohn S, Toretsky JA, Riegel AT, Wellstein A.

Oncogene. 2009 Sep 17;28(37):3296-306.

PMID: 19633684

13.

Effect of FGF-binding protein 3 on vascular permeability.

Zhang W, Chen Y, Swift MR, Tassi E, Stylianou DC, Gibby KA, Riegel AT, Wellstein A.

J Biol Chem. 2008 Oct 17;283(42):28329-37.

PMID: 18669637

14.

The genomic structure of the human SPEC1 gene reveals complex splicing and close promoter proximity to the AF1q translocation gene.

Pirone DM, Oberst MD, Stylianou D, Burbelo PD.

Gene. 2001 Aug 8;273(2):295-303.

PMID: 11595176

1.

A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.

Chrysostomou AC, Vrancken B, Koumbaris G, Themistokleous G, Aristokleous A, Masia C, Eleftheriou C, Iοannou C, Stylianou DC, Ioannides M, Petrou P, Georgiou V, Hatziyianni A, Lemey P, Vandamme AM, Patsalis PP, Kostrikis LG.

Viruses. 2021 Jun 9;13(6):1098.

PMID: 34207490 

2.

Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern.

Chrysostomou AC, Vrancken B, Haralambous C, Alexandrou M, Aristokleous A, Christodoulou C, Gregoriou I, Ioannides M, Kalakouta O, Karagiannis C, Koumbaris G, Loizides C, Mendris M, Papastergiou P, Patsalis PC, Pieridou D, Richter J, Schmitt M, Shammas C, Stylianou DC, Themistokleous G, The Comessar Network, Lemey P, Kostrikis LG.

Viruses. 2022 Dec 30;15(1):108.

PMID: 36680148 

3.

A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2.

Chrysostomou AC, Hezka Rodosthenous J, Topcu C, Papa C, Aristokleous A, Stathi G, Christodoulou C, Eleftheriou C, Stylianou DC, Kostrikis

Life (Basel). 2021 Oct 27;11(11):1146.

PMID: 34833022 

4.

Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains.

Chrysostomou AC, Topcu C, Stylianou DC, Hezka J, Kostrikis LG.

Infect Genet Evol. 2020 Jul;81:104243.

PMID: 32061896

5.

The development of inovirus-associated vector vaccines using phage-display technologies.

Stern Z, Stylianou DC, Kostrikis LG.

Expert Rev Vaccines. 2019 Sep;18(9):913-920.

PMID: 31373843

6.

HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection.

Paraskevis D, Stylianou DC, Hezka J, Stern Z, Oikonomopoulou M, Mamais I; Cyprus PWID Network, Kostrikis LG.

Sci Rep. 2019 Jul 11;9(1):10077.

PMID: 31296903

7.

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.

Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG.

Viruses. 2018 Dec 19;10(12):729.

PMID: 30572620

8.

HIV-1 transmission networks across Cyprus (2010-2012).

Kostrikis LG, Hezka J, Stylianou DC, Kostaki E, Andreou M, Kousiappa I, Paraskevis D, Demetriades I.

PLoS One. 2018 Apr 23;13(4):e0195660.

PMID: 29684083

9.

HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012.

Pineda-Peña AC, Theys K, Stylianou DC, Demetriades I; SPREAD/ESAR Program, Abecasis AB, Kostrikis LG.

Sci Rep. 2018 Jan 26;8(1):1702.

PMID: 29374182

10.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

PMID: 27262355

11.

Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.

Hassapis KA, Stylianou DC, Kostrikis LG.

Viruses. 2014 Dec 17;6(12):5047-76.

PMID: 25525909

12.

Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Stylianou DC, Auf der Maur A, Kodack DP, Henke RT, Hohn S, Toretsky JA, Riegel AT, Wellstein A.

Oncogene. 2009 Sep 17;28(37):3296-306.

PMID: 19633684

13.

Effect of FGF-binding protein 3 on vascular permeability.

Zhang W, Chen Y, Swift MR, Tassi E, Stylianou DC, Gibby KA, Riegel AT, Wellstein A.

J Biol Chem. 2008 Oct 17;283(42):28329-37.

PMID: 18669637

14.

The genomic structure of the human SPEC1 gene reveals complex splicing and close promoter proximity to the AF1q translocation gene.

Pirone DM, Oberst MD, Stylianou D, Burbelo PD.

Gene. 2001 Aug 8;273(2):295-303.

PMID: 11595176